PTGS2 and wet macular degeneration: Instead, a prospective double-blind randomized human study on the therapy of wet AMD with photodynamic therapy (PDT) supplemented with oral intake of the COX-2 inhibitor nabumetone resulted in the progression of macular atrophy (109).